128 related articles for article (PubMed ID: 1750507)
1. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation.
Inki P; Stenbäck F; Talve L; Jalkanen M
Am J Pathol; 1991 Dec; 139(6):1333-40. PubMed ID: 1750507
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study.
Athar M; An KP; Morel KD; Kim AL; Aszterbaum M; Longley J; Epstein EH; Bickers DR
Biochem Biophys Res Commun; 2001 Feb; 280(4):1042-7. PubMed ID: 11162632
[TBL] [Abstract][Full Text] [Related]
3. Syndecan in carcinomas produced from transformed epithelial cells in nude mice.
Inki P; Kujari H; Jalkanen M
Lab Invest; 1992 Mar; 66(3):314-23. PubMed ID: 1538586
[TBL] [Abstract][Full Text] [Related]
4. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes.
Inki P; Larjava H; Haapasalmi K; Miettinen HM; Grenman R; Jalkanen M
Eur J Cell Biol; 1994 Feb; 63(1):43-51. PubMed ID: 8005104
[TBL] [Abstract][Full Text] [Related]
5. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
6. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
7. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
8. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
9. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma].
Péterfia B; Hollósi P; Szilák L; Timár F; Paku S; Jeney A; Kovalszky I
Magy Onkol; 2006; 50(2):115-20. PubMed ID: 16888674
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of syndecan-1 in prostate cancer.
Kiviniemi J; Kallajoki M; Kujala I; Matikainen MT; Alanen K; Jalkanen M; Salmivirta M
APMIS; 2004 Feb; 112(2):89-97. PubMed ID: 15056224
[TBL] [Abstract][Full Text] [Related]
11. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
12. Localization of syndecan-1 in human gastric mucosa associated with ulceration.
Tanabe H; Yokota K; Kohgo Y
J Pathol; 1999 Feb; 187(3):338-44. PubMed ID: 10398089
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
14. Histogenesis and progression in ultraviolet light-induced tumors in hairless mice.
Kligman LH; Kligman AM
J Natl Cancer Inst; 1981 Dec; 67(6):1289-93. PubMed ID: 6947111
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.
Numa F; Hirabayashi K; Tsunaga N; Kato H; O'Rourke K; Shao H; Stechmann-Lebakken C; Varani J; Rapraeger A; Dixit VM
Cancer Res; 1995 Oct; 55(20):4676-80. PubMed ID: 7553648
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.
Sneed TB; Stanley DJ; Young LA; Sanderson RD
Cell Immunol; 1994 Feb; 153(2):456-67. PubMed ID: 8118875
[TBL] [Abstract][Full Text] [Related]
18. Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.
Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
Am J Hematol; 2001 May; 67(1):20-6. PubMed ID: 11279653
[TBL] [Abstract][Full Text] [Related]
19. Placental expression of syndecan 1 is diminished in preeclampsia.
Jokimaa VI; Kujari HP; Ekholm EM; Inki PL; Anttila L
Am J Obstet Gynecol; 2000 Dec; 183(6):1495-8. PubMed ID: 11120517
[TBL] [Abstract][Full Text] [Related]
20. Passive cigarette smoke exposure inhibits ultraviolet light B-induced skin tumors in SKH-1 hairless mice by blocking the nuclear factor kappa B signalling pathway.
Gottipati KR; Poulsen H; Starcher B
Exp Dermatol; 2008 Sep; 17(9):780-7. PubMed ID: 18312384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
